Zobrazeno 1 - 10
of 31
pro vyhledávání: '"R Degun"'
Autor:
Elyse Swallow, Se Hyun Kim, Dongyeol Lee, R Degun, Karen Stein, Sung Hee Lim, Keunchil Park, Yu Jung Kim, Myung-Ju Ahn, Philip Galebach, Dony Patel, Jong Seok Lee, Andrew Kageleiry, Kyung Ah Yoh, Jie Zhang
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 13:e239-e245
Aim This study aimed to describe characteristics, treatment patterns and survival among Korean patients diagnosed with locally advanced or metastatic anaplastic lymphoma kinase (ALK)+ non-small cell lung cancer (NSCLC). Methods A retrospective patien
Autor:
Jean-Francois Baladi, Giancarlo Benelli, Stephen Saletan, Nina Marinsek, Patrick Neven, R Degun, Guy Jerusalem, Fabrice Andre, Jie Zhang
Publikováno v:
Current Medical Research and Opinion. 30:1007-1016
International guidelines for hormone-receptor-positive (HR(+)), human epidermal growth factor receptor-2 negative (HER2(-)) advanced breast cancer (BC) recommend sequential lines of hormonal therapy (HT), and only recommend chemotherapy for patients
Autor:
Steve Spalding, Jasmin B Kuemmerle-Deschner, Andrew Zeft, R Degun, Isabelle Koné-Paut, Ahmet Gül, Dony Patel, Luca Cantarini, Seza Ozen, Kathleen G Lomax, Avi Livneh, Ivan Foeldvari, Jeffrey Weiss, Nina Marinsek, Helen J. Lachmann, Rolando Cimaz, Joost Frenkel, Pierre Quartier, Sinisa Savic, Véronique Hentgen
Publikováno v:
Arthritis careresearch. 69(4)
Objective: Periodic fever syndrome (PFS) conditions are characterized by recurrent attacks of fever and localized inflammation. This study examined the diagnostic pathway and treatments at tertiary centers for familial Mediterranean fever (FMF), tumo
Autor:
Philip Galebach, Adam Nosal, Oscar Arrieta, Keunchil Park, Miklos Pless, Edmond Bendaly, Elyse Swallow, Medha Sasane, Jie Zhang, Karen Stein, Jacques Cadranel, R Degun, Andrew Kageleiry, Dony Patel
Publikováno v:
Lung Cancer
Lung Cancer, Elsevier, 2016, 98, pp.9-14. ⟨10.1016/j.lungcan.2016.05.004⟩
Lung Cancer, 2016, 98, pp.9-14. ⟨10.1016/j.lungcan.2016.05.004⟩
Lung Cancer, Elsevier, 2016, 98, pp.9-14. ⟨10.1016/j.lungcan.2016.05.004⟩
Lung Cancer, 2016, 98, pp.9-14. ⟨10.1016/j.lungcan.2016.05.004⟩
Objectives Second-generation ALK inhibitors are recently available for ALK + non-small cell lung cancer (NSCLC) patients previously treated with crizotinib. This study described characteristics, treatment sequencing, and outcomes among locally advanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a013a13ecfe36113ffea5f3e398bac
https://hal.sorbonne-universite.fr/hal-01314916/file/Cadranel_Characteristics,.pdf
https://hal.sorbonne-universite.fr/hal-01314916/file/Cadranel_Characteristics,.pdf
Publikováno v:
Value in Health. 18(7)
Autor:
Andrew Kageleiry, D Kaen, OC Camacho, Gonzalo Recondo, Elyse Swallow, MB Mascheroni, S Balu, Oscar Arrieta, Karen Stein, Jie Zhang, C. Martin, R Degun, Barbara Ratto, Dony Patel
Publikováno v:
Value in Health. 18(7)
Objectives To describe patient characteristics, treatment patterns, and survival among Latin American patients diagnosed with locally-advanced/metastatic ALK+ non-small cell lung cancer (NSCLC). Methods Mexican and Argentine oncologists (N=5) reviewe
Autor:
Jean-Francois Ricci, Fabrice Andre, Jie Zhang, R Degun, Guy Jerusalem, Giancarlo Benelli, Stephen Saletan, Patrick Neven, Nina Marinsek
Publikováno v:
BMC Cancer
Background Healthcare resource utilization in breast cancer varies by disease characteristics and treatment choices. However, lack of clarity in guidelines can result in varied interpretation and heterogeneous treatment management and costs. In Europ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f236637438fd83abdd7b9dab4bea4cc
http://www.biomedcentral.com/1471-2407/15/787
http://www.biomedcentral.com/1471-2407/15/787
Publikováno v:
Value in Health. 19:A835-A836
Publikováno v:
Value in Health. 20:A550
Publikováno v:
Value in Health. 20:A853